Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...

Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional. In an interview with Fox News Digital, Dr. Dave Latshaw, CEO ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...

The alternative text for this image may have been generated using AI. Fig. 2: Timeline of anti-VEGF drug discovery and development. The alternative text for this image may have been generated using AI ...

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential benefits to millions of patients. However, the biotech and pharmaceutical companies that develop ...